Vertex Pharmaceuticals (Europe) Ltd, 10% Owner at CRISPR Therapeutics AG (CRSP), bought 181,484 shares at $24.97 ($4.4M) on 2018-12-24, disclosed to the SEC on 2018-12-26.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.58 | 22,742 | $514K | 11.8% |
| 2 | $22.58 | 22,742 | $514K | 11.8% |
| 3 | $22.91 | 2,603 | $60K | 1.4% |
| 4 | $22.91 | 2,603 | $60K | 1.4% |
| 5 | $23.18 | 11,742 | $272K | 6.2% |
| 6 | $23.18 | 11,742 |
| $272K |
| 6.2% |
| 7 | $24.97 | 53,655 | $1.3M | 30.7% |
| 8 | $24.97 | 53,655 | $1.3M | 30.7% |
| Total | $24.08 avg | 181,484 | $4.4M | 100% |